Taysha Gene Therapies Inc. logo

Taysha Gene Therapies Inc. (TSHA)

Market Closed
16 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS)
$
3. 62
-0.11
-2.9491%
$
1.44B Market Cap
- P/E Ratio
- Div Yield
2.75M Volume
-0.41 Eps
$ 3.73
Previous Close
Add Transaction
Day Range
3.6 3.75
Year Range
3.46 7.3
Want to track TSHA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Taysha Gene Therapies Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
MICHAEL DE LUZ
MICHAEL DE LUZ Williams & Novak, LLC
45,000 $79,650 $167,625 $87,975 110.45%
Raymond Debbane
Raymond Debbane Siren, L.L.C.
9.85M $25.54M $36.73M $11.19M 43.81%
David P. Cushing
David P. Cushing nVerses Capital, LLC
25,152 $171,285 $91,176 -$80,109 -46.77%
MA
Marie-Andree Alain Federation des caisses Desjardins du Quebec
500 $2,235 $1,865 -$370 -16.55%
Zachary Canonico
Zachary Canonico DIADEMA PARTNERS LP
522,619 $3.56M $1.95M -$1.61M -45.15%
Mark Schafer
Mark Schafer Police & Firemen's Retirement System of New Jersey
70,719 $208,877.46 $248,223.69 $39,346.23 18.84%
BGI
B Group Inc. B Group Inc.
1.8M $3.33M $6.62M $3.28M 98.56%
CW
Chung Wu Chung Wu Investment Group LLC
2,000 $11,000 $7,240 -$3,760 -34.18%
BM
Berkeley Meredith Hughes Financial Services LLC
6 $41 $22.38 -$18.62 -45.41%
Yuen Man Lee
Yuen Man Lee Persistent Asset Partners Ltd.
133,411 $908,529 $484,281.93 -$424,247.07 -46.7%
GFM
GF Fund Management Co. Ltd. GF Fund Management Co. Ltd.
5,797 $12,705.07 $20,956.15 $8,251.08 64.94%